Table 5. MMC Comparisons.

Characteristic	Total	MWRI	UCLA	t-test	Wilcoxon	Folded F
	(N = 35)	(N = 17)	(N = 18)	p-value	p-value	test
	(Mean ± SD)					(Variance)
Activation Panel
Viability of CD3+ cells	80.8 ± 15.6	77.0 ± 17.3	84.3 ± 13.4	0.143	0.040	0.276
CD4+ % of CD3+ cells	62.2 ± 11.9	66.5 ± 11.5	58.1 ± 11.0	0.033	0.010	0.851
CD38+DR+ % of CD4+ cells	9.2 ± 5.9	8.3 ± 4.5	10.1 ± 7.0	0.382	0.728	0.077
CD69+ % of CD4+ cells	60.3 ± 15.7	68.3 ± 11.6	52.7 ± 15.5	0.002	0.002	0.248
CD8+ % of CD3+ cells	30.4 ± 8.5	25.5 ± 6.6	35.0 ± 7.6	<.001	0.001	0.563
CD38+DR+ % of CD8+ cells	20.5 ± 10.0	16.4 ± 8.4	24.4 ± 10.0	0.015	0.023	0.466
CD69+ % of CD8+ cells	70.5 ± 14.9	75.9 ± 11.9	65.5 ± 16.0	0.037	0.028	0.246
Memory Panel
Viability of CD3+ cells	79.6 ± 13.4	74.7 ± 20.2	84.3 ± 13.0	0.083	0.144	0.064
CD4+ % of CD3+ cells	61.8 ± 11.6	67.4 ± 9.3	56.5 ± 11.3	0.004	0.002	0.442
CCR5+ % of CD4+ cells	68.9 ± 14.7	65.6 ± 13.8	71.7 ± 15.2	0.233	0.173	0.703
CD27+CD45RA+% of CD4+ cells	3.5 ± 6.1	1.6 ± 1.3	5.5 ± 8.3	0.079	0.814	<.001
CD27+CD45RA- % of CD4+ cells	20.3 ± 10.6	22.7 ± 12.0	17.8 ± 8.5	0.187	0.304	0.199
CD27-CD45RA+ % of CD4+ cells	1.2 ± 1.6	0.6 ± 0.6	1.8 ± 2.1	0.038	0.026	<.001
CD27-CD45RA- % of CD4+ cells	75.0 ± 13.7	75.1 ± 11.9	74.9 ± 15.8	0.957	0.614	0.279
CD8+ % of CD3+ cells	31.3 ± 8.7	26.9 ± 6.9	35.5 ± 8.3	0.002	0.004	0.473
CCR5+ % of CD8+ cells	81.3 ± 13.0	81.3 ± 13.9	81.3 ± 12.5	0.992	1.000	0.678
CD27+CD45RA+ % of CD8+ cells	3.7 ± 4.1	3.5 ± 3.4	4.0 ± 4.8	0.741	0.732	0.183
CD27+CD45RA- % of CD8+ cells	17.7 ± 11.1	19.6 ± 12.7	15.7 ± 9.1	0.325	0.417	0.207
CD27-CD45RA % of CD8+ cells	3.4 ± 6.5	2.2 ± 1.7	4.6 ± 9.1	0.314	0.652	<.001
CD27-CD45RA- % of CD8+ cells	75.2 ± 15.6	74.7 ± 15.6	75.7 ± 16.1	0.861	0.787	0.903